Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
15 p, 1.6 MB Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain / Salavert, Miguel (Hospital Universitari i Politècnic La Fe (València)) ; Cobo, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ; Pascual Hernández, Álvaro (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Aragón, Belén (Merck Sharp & Dohme Corp) ; Maratia, Stefano (Chiltern International Spain, Madrid, Spain) ; Jiang, Yiling (Merck Sharp & Dohme Ltd) ; Aceituno, Susana (Outcomes'10, Castellón de la Plana, Spain) ; Grau, Santiago (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Clostridium difficile infection (CDI) is the major cause of infectious nosocomial diarrhoea and is associated with considerable morbidity, mortality and economic impact. Bezlotoxumab administered in combination with standard of care (SoC) antibiotic therapy prevents recurrent CDI. [...]
2018 - 10.1007/s12325-018-0813-y
Advances in Therapy, Vol. 35 (october 2018) , p. 1920-1934  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.